You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 41 - 50 of 207728 results
  1. A Tunable, Tabletop, Synchrotron Light Source

    SBC: LYNCEAN TECHNOLOGIES, INC.            Topic: N/A

    N/A

    SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  2. Satellite Terminal (transportable) Non-Geostationary (STtNG)

    SBC: BASCOM HUNTER TECHNOLOGIES INC            Topic: N112170

    STtNG is a new U.S. Navy shipboard carry-on unclassified satellite communications terminal that will be capable of operating over non-geostationary satellites. These satellites will include, eventually, proliferated Low Earth Orbit (PLEO) systems, such as SpaceX Starlink and Amazon Kuiper, Medium Earth Orbit (MEO) systems, such as SES O3b Classic and SES mPOWER, Highly Elliptical Orbit (HEO) syste ...

    SBIR Phase II 2022 Department of DefenseNavy
  3. Organized Lipid Matrix: Fatty Acids and Choline in CF

    SBC: AVANTI POLAR LIPIDS, INC.            Topic: N/A

    Individuals with cystic fibrosis (CF) and pancreatic insufficiency (PI) are prone to fat malabsorption, putting them at risk for caloric, essential fatty acid, and choline deficiency, which, in turn, may lead to growth failure and a poorer clinical course. Many subjects with CF have essential fatty acid deficiency, characterized by decreased levels of linoleic acid and an increased triene/tetraene ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  4. Wearable Ultrasound for Imaging and Modulation

    SBC: THE ULTRAN GROUP, INC.            Topic: SB173001

    The Ultran Group, Inc., will further develop its wearable ultrasound technology and commercialize a Class II medical device for treatment of inflammation caused by rheumatoid arthritis. The developed technology will be a platform for additional therapies including pain treatment, immunotherapy, and cancer treatment. For this SBIR Phase II effort, Ultran will continue to work closely with the Unive ...

    SBIR Phase II 2019 Department of DefenseDefense Advanced Research Projects Agency
  5. Radiation Hardened By Design Structured ASICs for Reliable Digital Components

    SBC: MICROELECTRONICS RESEARCH DEVELOPMENT CORPORATION            Topic: N/A

    The Phase II effort will fully develop and realize a cost-effective, practically-oriented means to design and deliver radiation hardened digital electronic components capable of reliable operation in MDA and other DoD space and interceptor environments. Micro-RDC will accomplish this by working closely with ViASIC to integrate both new and existing radiation design hardening techniques into their ...

    SBIR Phase II 2007 Department of DefenseAir Force
  6. Combat Systems of the Future

    SBC: Advanced Systems/Supportability Engineering Technologies And Tools, Inc.            Topic: N05149

    The S-351 mini-sub is a prototype of the Dry Combat Submersible (DCS). This prototype was established as a means of risk reduction prior to a full commitment to the DCS program. Both of these platforms have an operational need to transit with minimum operator fatigue safely to a pre-defined point and covertly deploy and retrieve SEALS. To meet these operational needs, these platforms require upgra ...

    STTR Phase II 2017 Department of DefenseSpecial Operations Command
  7. Risperidone Subcutaneous Implant

    SBC: DELPOR INC            Topic: 101

    The objective of the proposed study is to develop a subcutaneous implant of risperidone that provides consistent therapeutic blood levels of the drug for 6 months after a single administration. The device is implanted during a simple, 10-minute, in-office procedure with local anesthetic. The benefits of the product include improved medication adherence, fewer relapses, ability to withdraw the medi ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Small blood pumps for small patients

    SBC: Vadovations, Inc.            Topic: NHLBI

    DESCRIPTION provided by applicant Heart failure and congenital heart defects threaten the lives of several thousand children each year The only FDA approved long term pediatric heart support device is the Berlin Heart Excor which is based on year old technology and is fraught with complications including blood clots forming in the device requiring frequent device replacement The recipien ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Fludase for Prevention of Influenza

    SBC: Nexbio, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Influenza is characterized by recurrent annual epidemics and periodic major worldwide pandemics. Because of the high disease-related morbidity and mortality, direct and indirect socio-economic impacts of influenza are enormous. In the last 100 years, there have been 3 major influenza pandemics. It has been about thirty years since the last pandemic. A new pand ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Crossbeam GPS Crosslink and Long Range Free Space Optical Communication

    SBC: SA PHOTONICS, LLC            Topic: AF161090

    n/a - no tech volume attached

    SBIR Phase II 2020 Department of DefenseAir Force
US Flag An Official Website of the United States Government